Interstitial lung diseases (ILDs) encompass more than 100 conditions. They represent a heterogeneous group of acute or chronic lung diseases that are characterized—to varying degrees—by inflammation and uncontrolled connective tissue formation, leading to scarring and stiffening of the lungs. The initial presentation of IPF is insidious dyspnea on exertion and a dry cough; the prognosis is poor.
Autoren
- Melika Piric
- Prof. Dr. med. Philipp Markart
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Interstitial Lung Diseases
Update on Idiopathic Pulmonary Fibrosis
- Psychedelic-assisted therapy
Current status of PAT
- Psoriasis and Obesity: Effects of Incretin-Based Therapies
Clinical trials shed light on the potential of semaglutide, liraglutide, and tirzepatide
- Eosinophils in the Blood in COPD
How many measurements are needed to be sure?
- From symptom to diagnosis
Abdominal Pain – Von Meyenburg Complexes of the Liver
- Multiple sclerosis
Physical and psychosocial fatigue have the greatest impact on HRQoL
- Congenital Vascular Malformations
Personalized Treatment Before a Planned Pregnancy
- Hyperhidrosis: Keep a Cool Head